Hence, the present study was undertaken to assess the mechanistic hepatoprotective roles of resveratrol against changes contributed to HFFD-induced metabolic syndrome in rats via evaluation of oxidative/antioxidant molecules, NF-kβ signaling, lipid-related genes (SREBP1-c/PPARα), and IRS-2. This evidence concerns the gene PPARA and metabolic syndrome.